| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/16/1997 | US5698763 Transgenic animals lacking prion proteins |
| 12/16/1997 | US5698687 Rna molecule containing modified nucloside |
| 12/16/1997 | US5698686 Yeast telomerase compositions |
| 12/16/1997 | US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response |
| 12/16/1997 | US5698520 Peptide related to human programmed cell death and DNA encoding the same |
| 12/16/1997 | US5698517 Thyroxin-binding HSA fragments |
| 12/16/1997 | US5698446 Methods and compositions for inhibiting production of replication competent virus |
| 12/16/1997 | US5698445 Human PAK65 |
| 12/16/1997 | US5698444 Isolated amino acid compound |
| 12/16/1997 | US5698443 Tissue specific viral vectors |
| 12/16/1997 | US5698442 DNA encoding an 18 Kd CDK6 inhibiting protein |
| 12/16/1997 | US5698439 Novel malignant cell type markers of the interior nuclear matrix |
| 12/16/1997 | US5698436 Introduction and expression of foreign genetic material in epithelial cells |
| 12/16/1997 | US5698435 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 12/16/1997 | US5698431 Deficient in virion host shutoff function, profoundly attenuated in its ability to replicate at periphery and in the nervous system, and reactivate from latency |
| 12/16/1997 | US5698428 Human PAK65 |
| 12/16/1997 | US5698426 Surface expression libraries of heteromeric receptors |
| 12/16/1997 | US5698425 Method of protecting plants by transformation with genes for the synthesis of antipathogenic substances |
| 12/16/1997 | US5698424 Capsid forming and cystein modified chimaeric MS2-coat protein |
| 12/16/1997 | US5698423 Method for producing azadirachtin by cell culture of Azadirachta indica |
| 12/16/1997 | US5698421 Ribonucleoprotein particles for cleaving double-stranded DNA and inserting an RNA/DNA molecule into the cleavage site |
| 12/16/1997 | US5698417 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 12/16/1997 | US5698416 Dna sequence encoding proteins |
| 12/16/1997 | US5698415 Polypeptide |
| 12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
| 12/16/1997 | US5698400 Detection of mutation by resolvase cleavage |
| 12/16/1997 | US5698396 Method for identifying auto-immunoreactive substances from a subject |
| 12/16/1997 | US5698392 Nucleic acid fragments and diagnostic reagents derived from the HHV6/SIE genome and procedures for diagnosing HHV6 infections |
| 12/16/1997 | US5698390 Incubating sample including hepatitis c polypeptide that binds to antibody under conditions that allow for formation of antibody-antigen complex |
| 12/16/1997 | US5698389 Polypeptides |
| 12/16/1997 | US5698202 Deletion of e-1 gene and replacement with cytomegalovirus promoter sequence which controls the expression of dna coding for a rabies virus protein useful in single-dose rabies vaccines, also partial deletion of e-3 gene |
| 12/16/1997 | US5698196 Antibodies specific for neutrophic chemotactic factor |
| 12/16/1997 | US5698178 Binding a multidrug transporter protein and an antigen associated with a tumor or infectious agent |
| 12/16/1997 | CA2058441C Crystalline r-h-gm-csf and method for the preparation |
| 12/16/1997 | CA1339583C Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 12/16/1997 | CA1339582C Monoclonal antibodies and methods for diagnosis of phytophthora infection |
| 12/16/1997 | CA1339581C Enzymatic detergent and bleaching composition |
| 12/11/1997 | WO1997046963A1 Multicomponent analysis method including the determination of a statistical confidence interval |
| 12/11/1997 | WO1997046885A1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
| 12/11/1997 | WO1997046884A1 Materials and methods for detection of breast cancer |
| 12/11/1997 | WO1997046714A1 Monitoring hybridization during pcr |
| 12/11/1997 | WO1997046713A1 Method and compositions for controlling gene expression |
| 12/11/1997 | WO1997046712A2 System and method for carrying out and monitoring biological processes |
| 12/11/1997 | WO1997046711A1 Artificial mismatch hybridization |
| 12/11/1997 | WO1997046710A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
| 12/11/1997 | WO1997046709A2 NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING $i(CHLAMYDIA PNEUMONIAE) |
| 12/11/1997 | WO1997046708A1 Passive internal references for the detection of nucleic acid amplification products |
| 12/11/1997 | WO1997046707A2 System and method for monitoring for dna amplification by fluorescence |
| 12/11/1997 | WO1997046705A1 Methylation specific detection |
| 12/11/1997 | WO1997046704A1 Sequencing by ligation of encoded adaptors |
| 12/11/1997 | WO1997046703A1 Optimally fluorescent oligonucleotides |
| 12/11/1997 | WO1997046702A1 Genetic alterations associated with prostate cancer |
| 12/11/1997 | WO1997046701A1 Mismatch endonucleases and uses thereof in identifying mutations in targeted polynucleotide strands |
| 12/11/1997 | WO1997046700A1 Nucleotide probes and method for determining hla dqb1 typing |
| 12/11/1997 | WO1997046697A3 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046697A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 12/11/1997 | WO1997046693A1 Virus-like particles useful as a vector for delivering nucleic acid |
| 12/11/1997 | WO1997046692A1 Nematode-inducible plant gene promoter |
| 12/11/1997 | WO1997046691A1 Integration cassette for improvement of transgenesis in eukaryotes |
| 12/11/1997 | WO1997046690A1 Enhancement of gene expression |
| 12/11/1997 | WO1997046689A1 Fungal metallo protease genes |
| 12/11/1997 | WO1997046688A1 Lipid kinase |
| 12/11/1997 | WO1997046687A1 Vectors comprising sar elements |
| 12/11/1997 | WO1997046686A2 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 12/11/1997 | WO1997046684A1 Non-activated receptor complex proteins and uses thereof |
| 12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
| 12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
| 12/11/1997 | WO1997046681A2 GALANIN RECEPTOR GalR2 |
| 12/11/1997 | WO1997046680A1 Dna encoding dp. 75 and a process for its use |
| 12/11/1997 | WO1997046679A1 Cyclin-c variants, and diagnostic and therapeutic uses thereof |
| 12/11/1997 | WO1997046678A1 Nucleic acids and polypeptides related to presenilin |
| 12/11/1997 | WO1997046677A1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
| 12/11/1997 | WO1997046676A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 12/11/1997 | WO1997046675A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
| 12/11/1997 | WO1997046674A1 Spruce budworm antifreeze proteins, genes and methods of using same |
| 12/11/1997 | WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression |
| 12/11/1997 | WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | WO1997046670A1 Programmed sequential mutagenesis |
| 12/11/1997 | WO1997046669A1 Transgenic mammals lacking expression of amylin |
| 12/11/1997 | WO1997046666A1 Modified small rna viruses |
| 12/11/1997 | WO1997046664A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 12/11/1997 | WO1997046663A1 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 12/11/1997 | WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/11/1997 | WO1997046588A1 Cellular internalization of pigr stalk and associated ligands |
| 12/11/1997 | WO1997046586A1 Novel human receptor type tyrosine kinase-like protein |
| 12/11/1997 | WO1997046585A2 Fragments of leptin (ob protein) |
| 12/11/1997 | WO1997046584A1 Exendin analogues, processes for their preparation and medicaments containing them |
| 12/11/1997 | WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 12/11/1997 | WO1997046573A1 Method of inhibiting antigen processing, chimeric proteins reflecting this method, and methods of expressing those proteins |
| 12/11/1997 | WO1997046572A1 Transgenic animals expressing artificial epitope-tagged proteins |
| 12/11/1997 | WO1997046571A1 Phosphorothioate oligonucleotides that bind to the v3-loop and uses thereof |
| 12/11/1997 | WO1997046570A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 12/11/1997 | WO1997046569A2 2'-substituted nucleosides and oligonucleotide derivatives |
| 12/11/1997 | WO1997046263A1 Il-12 gene therapy of tumors |
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
| 12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/11/1997 | WO1997046223A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 12/11/1997 | WO1997046206A2 Human thyrotropin receptor compositions and use thereof |